What is the role of sipuleucel-T in the treatment of patients with advanced prostate cancer? An update on the evidence by Rachel Hu, Daniel J. George, Tian Zhang

Get full text

Clear Cell Renal Cell Carcinoma: From Biology to Treatment by Adam M. Kase, Daniel J. George, Sundhar Ramalingam

Get full text

Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T? by Rhonda L. Bitting, Andrew J. Armstrong, Daniel J. George

Get full text

Control of renal cell carcinoma brain metastases with cabozantinib following progression on immune checkpoint inhibitor therapy by Cierra Hong, Kristen A. Batich, Garland Almquist, Luis Villa, Daniel J. George, Tian Zhang

Get full text

Functional impact of androgen‐targeted therapy on patients with castration‐resistant prostate cancer by Tomasz M. Beer, Neal Shore, Alicia Morgans, Kerri Winters‐Stone, Jeffrey S. Wefel, Daniel J. George

Get full text

Understanding what matters to metastatic castration‐resistant prostate cancer (mCRPC) patients when considering treatment options: A US patient preference survey by Daniel J. George, Ateesha F. Mohamed, Jui‐Hua Tsai, Milad Karimi, Ning Ning, Sayeli Jayade, Marc Botteman

Get full text

Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond by Jason Zhu, Andrew J. Armstrong, Terence W. Friedlander, Won Kim, Sumanta K. Pal, Daniel J. George, Tian Zhang

Get full text

Novel therapies are changing treatment paradigms in metastatic prostate cancer by Eric Powers, Georgia Sofia Karachaliou, Chester Kao, Michael R. Harrison, Christopher J. Hoimes, Daniel J. George, Andrew J. Armstrong, Tian Zhang

Get full text

Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab by Tian Zhang, Brian I. Rini, Moshe C. Ornstein, Daniel J. George, Chester Kao, Landon C. Brown, Kunal Desai, Emily N. Kinsey

Get full text

Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer by Fred Saad, Daniel J. George, Michael S. Cookson, Daniel R. Saltzstein, Ronald Tutrone, Alberto Bossi, Bruce Brown, Bryan Selby, Sophia Lu, Bertrand Tombal, Neal D. Shore

Get full text

Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer by Joe M. O’Sullivan, Rana R. McKay, Kambiz Rahbar, Karim Fizazi, Daniel J. George, Bertrand Tombal, Anja Schmall, Per Sandström, Frank Verholen, Neal Shore

Get full text

Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial by Robert J. Motzer, Jean-François Martini, Xinmeng J. Mu, Michael Staehler, Daniel J. George, Olga Valota, Xun Lin, Hardev S. Pandha, Keith A. Ching, Alain Ravaud

Get full text

Rewiring of the N-Glycome with prostate cancer progression and therapy resistance by William Butler, Colin McDowell, Qing Yang, Yiping He, Yue Zhao, J. Spencer Hauck, Yinglu Zhou, Hong Zhang, Andrew J. Armstrong, Daniel J. George, Richard Drake, Jiaoti Huang

Get full text

Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma by Thomas Powles, Toni K. Choueiri, Robert J. Motzer, Eric Jonasch, Sumanta Pal, Nizar M. Tannir, Sabina Signoretti, Rajesh Kaldate, Christian Scheffold, Evelyn Wang, Dana T. Aftab, Bernard Escudier, Daniel J. George

Get full text

Correction to: Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma by Thomas Powles, Toni K. Choueiri, Robert J. Motzer, Eric Jonasch, Sumanta Pal, Nizar M. Tannir, Sabina Signoretti, Rajesh Kaldate, Christian Scheffold, Evelyn Wang, Dana T. Aftab, Bernard Escudier, Daniel J. George

Get full text

Pembrolizumab in men with heavily treated metastatic castrate‐resistant prostate cancer by Matthew D. Tucker, Jason Zhu, Daniele Marin, Rajan T. Gupta, Santosh Gupta, William R. Berry, Sundhar Ramalingam, Tian Zhang, Michael Harrison, Yuan Wu, Patrick Healy, Stacey Lisi, Daniel J. George, Andrew J. Armstrong

Get full text

Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancerR... by Celestia S. Higano, Daniel J. George, Neal D. Shore, Oliver Sartor, Kurt Miller, Peter S. Conti, Cora N. Sternberg, Fred Saad, Juan Pablo Sade, Joaquim Bellmunt, Matthew R. Smith, Kumari Chandrawansa, Per Sandström, Frank Verholen, Bertrand Tombal

Get full text

Safety and efficacy of first-line nivolumab plus ipilimumab alternating with nivolumab monotherapy in patients with advanced renal cell carcinoma: the non-randomised, open-label, p... by Scott S Tykodi, Daniel J George, Jeff Yorio, Lucio N Gordan, Joshua Zhang, Jennifer L Johansen, Arash Rezazadeh Kalebasty, David R Spigel, Samith T Kochuparambil, Ana M Molina, Heidi McKean, Nishan Tchekmedyian, Margarita Askelson, Thomas E Hutson

Get full text

LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types by Ramy Sedhom, Santosh Gupta, Yuan Wu, Jason Zhu, Daniele Marin, Michael R Harrison, Landon C Brown, Matthew D Tucker, Eric B Schwartz, Chester Kao, Matthew K Labriola, Rajan T Gupta, Daniel J George, Emmanuel S Antonarakis, Andrew J Armstrong

Get full text

Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer by Tian Zhang, Anika Agarwal, R. Garland Almquist, Daniella Runyambo, Sally Park, Elizabeth Bronson, Rengasamy Boominathan, Chandra Rao, Monika Anand, Taofik Oyekunle, Patrick Healy, Megan A. McNamara, Kathryn Ware, Jason A. Somarelli, Daniel J. George, Andrew J. Armstrong

Get full text